mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.0072 |
0.9 |